# Hyperglycemia and Lung Cancer—A Possible Relationship

## TL;DR

This paper explores the possible link between high blood sugar and lung cancer, suggesting that managing glucose levels could improve cancer treatment outcomes.

## Contribution

The paper highlights the overlooked relationship between hyperglycemia and lung cancer and suggests therapeutic strategies based on shared molecular pathways.

## Key findings

- Hyperglycemia is frequently observed in lung cancer patients but often ignored.
- Uncontrolled blood sugar levels are associated with worse cancer treatment outcomes.
- Shared molecular pathways between hyperglycemia and lung cancer suggest potential therapeutic targets.

## Abstract

Glucose is the main source of energy in human cells. Elevated levels of glucose are one of the most common metabolic disorders, and it has been shown to have a significant, mostly negative, effect on multiple chronic and acute diseases. Lung cancer remains one of the biggest challenges for treatment in modern medicine, with a high prevalence, incidence and mortality. Hyperglycemia is not uncommon in patients with lung cancer; however, it is usually overlooked. Patients with unregulated glycemia and lung cancer have been shown to have worse outcomes, reduced therapeutic effect and more complications during treatment. Studies have identified multiple molecular pathways common in both hyperglycemia and lung cancer; however, no clear correlation has been identified. By understanding these signaling pathways, we can influence the outcome therapeutically and thereby improve the survival of patients with lung cancer.